ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 5, 1990

October issue of Business & Regulatory Report included.

November 5, 2004

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980